...
首页> 外文期刊>Journal of Clinical and Diagnostic Research >Adenoid Cystic Carcinoma of Cervix:Treatment Strategy
【24h】

Adenoid Cystic Carcinoma of Cervix:Treatment Strategy

机译:宫颈腺样囊性癌的治疗策略

获取原文

摘要

Adenoid Cystic Carcinoma (ACC) of cervix behaves aggressively and it has a propensity for local infiltration, invasion in lymphatic vessels as well as perineural spaces, with subsequent haematogenous spread. In advanced disease (Stage III and IV), outcome is invariably poor. Moreover, these cases have a high tendency to recur locally and also to metastasize to distant sites. There are no standard treatment protocols because of rarity of disease. The guidelines for its management are established similarly as for staged squamous cell carcinoma of cervix. Therefore, recommended treatment in advanced disease is aggressive multimodality treatment, which includes chemotherapy and radiotherapy. We are presenting a case of adenoid cystic carcinoma of cervix in 55 years old patient, staged as III B. The patient was treated with concomitant radiotherapy and chemotherapy. The patient responded well to treatment and is disease free, three years after treatment.
机译:宫颈腺样囊性癌(ACC)表现为侵袭性,具有局部浸润,浸润淋巴管和神经周间隙以及随后发生血肿的倾向。在晚期疾病(III和IV期)中,结果总是很差。而且,这些病例极有可能在局部复发,并转移到远处。由于疾病罕见,因此没有标准的治疗方案。其管理指南的建立与子宫颈鳞状细胞癌的建立类似。因此,在晚期疾病中推荐的治疗方法是积极的多模式治疗,包括化学疗法和放射疗法。我们正在介绍一名55岁患者的宫颈腺样囊性癌,分期为IIIB。该患者接受了放疗和化疗。治疗三年后,患者对治疗反应良好且无疾病。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号